FORM 8-K

Company

Eloxx Pharmaceuticals, Inc.

Filed

February 13, 2004

Period of Report

February 12, 2004

Accession Number

0000903100-04-000068

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →